Despite being relatively rare, NAION is a significant cause of blindness in the U.S
It is a triple-agonist, which is a major focus in current scientific research
Sources Phase 2 Retatrutide Trial (NEJM) Triple hormone receptor agonist retatrutide for metabolic dysfunctionassociated steatotic liver disease Triple Agonism Review (PMC) Triple Agonism Based Therapies for Obesity Retatrutide Game Changer Review RetatrutideA Game Changer in Obesity Pharmacotherapy The Atlantic GLP3 Underground Market GoodRx Retatrutide Availability & Dosage Retatrutide for Weight Loss: Availability, Dosage, and More Phase 3 Trial Update (Clinical Trials Arena) Lillys triple G agonist boasts 28.7% weight loss in Phase III trial Retatrutide FDA Status 2026 Retatrutide FDA Approval Status 2026: Phase 3 Results Update GLP3 Retatrutide FAQ (Expert) GLP3 Retatrutide Peptide Expert FAQ Dr
A simple daily supplement that promotes overall wellness and complements an active, health-conscious lifestyle
As an in-network provider for UnitedHealthcare, Shapely helps patients access physician-led weight loss care, including medical consultations, lifestyle coaching with a dietitian, and weight loss prescriptions